SUBJECTS : Therapeutics | Pharmacology | Antibodie
Antibody Therapeutics: 2023, vol: 6, issue: 3
- 1)- Yuwei Zhou, Ziru Huang, Yushu Gou, Siqi Liu, Wei Yang, Hongyu Zhang, Anthony Mackitz Dzisoo, Jian Huang. AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains. Antibody therapeutics. 2023, 6 (3): 147-156
Cited : 3Read More - 2)- Jing Chang, Christoph Rader, Haiyong Peng. A mammalian cell display platform based on scFab transposition. Antibody therapeutics. 2023, 6 (3): 157-169Cited : 1Read More
- 3)- Shiyong Gong, Chengbin Wu. Efficient production of bispecific antibodies-optimization of transfection strategy leads to high-level stable cell line generation of a Fabs-in-tandem immunoglobin. Antibody therapeutics. 2023, 6 (3): 170-179Cited : 1Read More
- 4)- . Correction: AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains. Antibody therapeutics. 2023, 6 (3): 180Cited : 0Read More
- 5)- . Correction to: A mammalian cell display platform based on scFab transposition. Antibody therapeutics. 2023, 6 (3): 181Cited : 0Read More
- 6)- Anthony M Deacy, Samuel Ken-En Gan. The influence of variable-heavy chain families on IgG, , , FcγRs and B-cell superantigens protein G and L binding using biolayer interferometry. Antibody therapeutics. 2023, 6 (3): 182-193Cited : 0Read More
- 7)- Zhouyi Wu, Gangling Xu, Wu He, Chuanfei Yu, Wanqiu Huang, Shirui Zheng, Dian Kang, Michael H Xie, Xingjun Cao, Lan Wang, Kaikun Wei. Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305. Antibody therapeutics. 2023, 6 (3): 194-210Cited : 0Read More
- 8)- Mariya B Shapiro, Jacqueline Boucher, Anna Brousseau, Amin Dehkharghani, Justin Gabriel, Vishal Kamat, Ketan Patil, Feng Gao, Jennifer Walker, Ryan Kelly, Colby A Souders. Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform. Antibody therapeutics. 2023, 6 (3): 211-223Cited : 0Read More
